Common Stock, Shares, Issued of AVAI BIO, INC. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
AVAI BIO, INC. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • AVAI BIO, INC. Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 138,031,533, a 0.66% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

AVAI BIO, INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 138,031,533 +899,953 +0.66% 31 Dec 2025 10-Q 12 Feb 2026 2026 Q3
Q3 2025 137,829,465 +5,957,023 +4.5% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 137,511,233 +20,493,327 +18% 30 Jun 2025 10-Q 12 Aug 2025 2026 Q1
Q1 2025 137,363,513 +20,195,607 +17% 31 Mar 2025 10-Q 12 Feb 2026 2026 Q3
Q4 2024 137,131,580 +52,337,202 +62% 31 Dec 2024 10-Q 07 Feb 2025 2025 Q3
Q3 2024 131,872,442 30 Sep 2024 10-Q/A 21 Jan 2025 2025 Q2
Q2 2024 117,017,906 +52,514,095 +81% 30 Jun 2024 10-Q/A 21 Jan 2025 2025 Q1
Q1 2024 117,167,906 +78,664,095 +204% 31 Mar 2024 10-K/A 19 Feb 2025 2024 FY
Q4 2023 84,794,378 +52,563,295 +163% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q2 2023 64,503,811 +38,187,728 +145% 30 Jun 2023 10-Q 16 Aug 2023 2023 Q1
Q1 2023 38,503,811 +12,187,728 +46% 31 Mar 2023 10-K/A 19 Feb 2025 2024 FY
Q4 2022 32,231,083 +5,915,000 +22% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 32,231,083 +5,915,000 +22% 30 Sep 2022 10-Q 10 Nov 2022 2023 Q2
Q2 2022 26,316,083 +34,483 +0.13% 30 Jun 2022 10-Q 19 Aug 2022 2023 Q1
Q1 2022 26,316,083 +34,483 +0.13% 31 Mar 2022 10-K/A 13 Jul 2023 2022 FY
Q4 2021 26,316,083 +26,312,133 31 Dec 2021 10-Q 14 Feb 2022 2022 Q3
Q3 2021 26,316,083 +34,483 +0.13% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q2
Q2 2021 26,281,600 -400 -0% 30 Jun 2021 10-Q 23 Aug 2021 2021 Q1
Q1 2021 26,281,600 +25,217,520 +2370% 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q4 2020 3,950* -1,064 31 Dec 2020 10-Q 18 Feb 2021 2021 Q3
Q3 2020 26,281,600 +26,276,586 30 Sep 2020 10-Q 15 Nov 2021 2022 Q2
Q2 2020 26,282,000 +26,276,986 30 Jun 2020 10-Q 20 Aug 2020 2021 Q1
Q1 2020 1,064,080 +1,059,066 31 Mar 2020 10-K/A 18 Aug 2021 2021 FY
Q4 2019 5,014* 0 31 Dec 2019 10-Q 04 Feb 2020 2020 Q3
Q3 2019 5,014* 0 30 Sep 2019 10-Q 13 Nov 2019 2020 Q2
Q2 2019 5,014* +1,014 30 Jun 2019 10-Q/A 17 Oct 2019 2020 Q1
Q1 2019 5,014* +1,014 31 Mar 2019 10-K 13 Aug 2020 2020 FY
Q4 2018 5,014* 31 Dec 2018 10-Q 17 Jan 2019 2019 Q3
Q3 2018 5,014* 30 Sep 2018 10-Q 14 Nov 2018 2019 Q2
Q2 2018 4,000* 30 Jun 2018 10-Q 25 Jul 2018 2019 Q1
Q1 2018 4,000* 31 Mar 2018 10-K 15 Jul 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.